Robert Musci

4PUBLICATIONS
12CO-AUTHORS
Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 26, 2026
Comment on Kura et al. Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. Vaccines 2026, 14, 411.

|May 22, 2026
Estimated Cost of Adverse Event Management in Treatment Naïve Non-small Cell Lung Cancer Patients with Common EGFR Mutations Treated with Amivantamab Plus Lazertinib and Osimertinib Plus Chemotherapy.

|Sep 05, 2024
Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes.

Alexia Kieffer, Matthieu Beuvelet, Gerald Moncayo

|Aug 15, 2022
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model.

Alexia Kieffer, Matthieu Beuvelet, Aditya Sardesai

Pageof 1

Frequent Collaborators

2 joint publications

Aditya Sardesai

1 joint publications

Sandra Milev

1 joint publications

Julie Roiz

1 joint publications

Jason K H Lee